FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116255 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Deblina Ghosh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; Massey Comprehensive Cancer Center, Virginia Commonwe…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Drug Resistance, Neoplasm, Proto-Oncogene Proteins p21(ras), Pyridines. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; Massey Comprehensive Cancer Center, Virginia Commonwealth University, USA.
- Department of Surgery, Virginia Commonwealth University, Richmond, VA, USA; Massey Comprehensive Cancer Center, Virginia Commonwealth University, USA.
- David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; Massey Comprehensive Cancer Center, Virginia Commonwealth University, USA. Electronic address: Said.Sebti@vcuhealth.org.
Förderung
- National Institutes of Health
Zitieren
APA
Ghosh, D., Kazi, A., Vasiyani, H. K. K., Vudatha, V., Lecomte, N., Iacobuzio-Donahue, C., Trevino, J., & Sebti, S. M. (2026). FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116255
Vancouver
Ghosh D, Kazi A, Vasiyani HKK, Vudatha V, Lecomte N, Iacobuzio-Donahue C, et al. FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116255
BibTeX
@article{Ghosh2026,
author = {Ghosh, Deblina and Kazi, Aslamuzzaman and Vasiyani, Hitesh Kumar Kantilal and Vudatha, Vignesh and Lecomte, Nicolas and Iacobuzio-Donahue, Christine and Trevino, Jose and Sebti, Said M},
title = {FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116255}
}
EUVIMED